Cargando…

Optimizing colorectal cancer screening by race and sex: Microsimulation analysis II to inform the American Cancer Society colorectal cancer screening guideline

BACKGROUND: Colorectal cancer (CRC) risk varies by race and sex. This study, 1 of 2 microsimulation analyses to inform the 2018 American Cancer Society CRC screening guideline, explored the influence of race and sex on optimal CRC screening strategies. METHODS: Two Cancer Intervention and Surveillan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meester, Reinier G. S., Peterse, Elisabeth F. P., Knudsen, Amy B., de Weerdt, Anne C., Chen, Jennifer C., Lietz, Anna P., Dwyer, Andrea, Ahnen, Dennis J., Siegel, Rebecca L., Smith, Robert A., Zauber, Ann G., Lansdorp‐Vogelaar, Iris
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055229/ https://www.ncbi.nlm.nih.gov/pubmed/29846942 http://dx.doi.org/10.1002/cncr.31542

Ejemplares similares

The impact of the rising colorectal cancer incidence in young adults on the optimal age to start screening: Microsimulation analysis I to inform the American Cancer Society colorectal cancer screening guideline
por: Peterse, Elisabeth F. P., et al.
Publicado: (2018)

Comparing the Cost-Effectiveness of Innovative Colorectal Cancer Screening Tests
por: Peterse, Elisabeth F P, et al.
Publicado: (2020)

Unequal Recovery in Colorectal Cancer Screening Following the COVID-19 Pandemic: A Comparative Microsimulation Analysis
por: de Lima, Pedro Nascimento, et al.
Publicado: (2022)

Cost‐effectiveness of prophylactic hysterectomy in first‐degree female relatives with Lynch syndrome of patients diagnosed with colorectal cancer in the United States: a microsimulation study
por: Alblas, Maaike, et al.
Publicado: (2021)

Risk‐stratified strategies in population screening for colorectal cancer
por: Lansdorp‐Vogelaar, Iris, et al.
Publicado: (2021)

Public Health Impact of Achieving 80% Colorectal Cancer Screening Rates in the United States by 2018
por: Meester, Reinier G S, et al.
Publicado: (2015)

An Evolutionary Algorithm to Personalize Stool-Based Colorectal Cancer Screening
por: van Duuren, Luuk A., et al.
Publicado: (2022)

Cost-effectiveness of Colorectal Cancer Screening
por: Lansdorp-Vogelaar, Iris, et al.
Publicado: (2011)

652: IMPACT AND RECOVERY FROM COVID-19-RELATED DISRUPTIONS IN COLORECTAL CANCER SCREENING AND CARE: A SCENARIO ANALYSIS
por: Puttelaar, Rosita van den, et al.
Publicado: (2022)

Impact and Recovery from COVID-19–Related Disruptions in Colorectal Cancer Screening and Care in the US: A Scenario Analysis
por: van den Puttelaar, Rosita, et al.
Publicado: (2023)

Cost-Effectiveness of Colonoscopy-Based Colorectal Cancer Screening in Childhood Cancer Survivors
por: Gini, Andrea, et al.
Publicado: (2019)

Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a microsimulation modelling study
por: Buskermolen, Maaike, et al.
Publicado: (2019)

Development and Validation of Three Regional Microsimulation Models for Predicting Colorectal Cancer Screening Benefits in Europe
por: Gini, Andrea, et al.
Publicado: (2021)

Cost-effectiveness of a multitarget stool DNA test for colorectal cancer screening of Medicare beneficiaries
por: Naber, Steffie K., et al.
Publicado: (2019)

Colorectal Cancer Screening in the Novel Coronavirus Disease-2019 Era
por: Dekker, Evelien, et al.
Publicado: (2020)

Colorectal Cancer Screening within Colonoscopy Capacity Constraints: Can FIT-Based Programs Save More Lives by Trading off More Sensitive Test Cutoffs against Longer Screening Intervals?
por: McFerran, Ethna, et al.
Publicado: (2022)

Projected long-term effects of colorectal cancer screening disruptions following the COVID-19 pandemic
por: Nascimento de Lima, Pedro, et al.
Publicado: (2023)

Cost-effectiveness and budget impact analyses of a colorectal cancer screening programme in a high adenoma prevalence scenario using MISCAN-Colon microsimulation model
por: Arrospide, Arantzazu, et al.
Publicado: (2018)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Impact of COVID-19 and suspension of colorectal cancer screening on incidence and stage distribution of colorectal cancers in the Netherlands
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2022)

CMOST: an open-source framework for the microsimulation of colorectal cancer screening strategies
por: Prakash, Meher K., et al.
Publicado: (2017)

Optimising colorectal cancer screening in Shanghai, China: a modelling study
por: Cenin, Dayna, et al.
Publicado: (2022)

Urban density differences in colorectal cancer screening participation and screening yield in The Netherlands
por: de Klerk, Clasine M., et al.
Publicado: (2022)

Cost-effectiveness analysis of colorectal cancer screening in a low incidence country: The case of Saudi Arabia
por: Naber, Steffie K., et al.
Publicado: (2021)

Personalised colorectal cancer screening strategies: Information needs of the target population
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Costs and outcomes of Lynch syndrome screening in the Australian colorectal cancer population
por: Cenin, Dayna R, et al.
Publicado: (2018)

Cost-effectiveness analysis of colorectal cancer screening in Shanghai, China: A modelling study
por: Wang, Jie, et al.
Publicado: (2022)

Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening
por: van der Vlugt, Manon, et al.
Publicado: (2017)

Impact of delayed screening invitations on screen-detected and interval cancers in the Dutch colorectal cancer screening programme: individual-level data analysis
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2023)

Participation in faecal immunochemical testing-based colorectal cancer screening programmes in the northwest of Europe
por: Toes-Zoutendijk, Esther, et al.
Publicado: (2019)

Cost-Effectiveness of Risk-Stratified Colorectal Cancer Screening Based on Polygenic Risk: Current Status and Future Potential
por: Naber, Steffie K, et al.
Publicado: (2019)

Optimizing Patient Risk Stratification for Colonoscopy Screening and Surveillance of Colorectal Cancer: The Role for Linked Data
por: Preen, David B., et al.
Publicado: (2017)

783 IMPACT OF COVID-19 RELATED DISRUPTIONS TO COLORECTAL CANCER SCREENING PROGRAMS IN THREE COUNTRIES: A COMPARATIVE MODELLING STUDY
por: De Jonge, Lucie, et al.
Publicado: (2021)

Impact of screening and follow‐up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC‐AIM microsimulation model
por: Fisher, Deborah A., et al.
Publicado: (2020)

The national FIT-based colorectal cancer screening program in the Netherlands during the COVID-19 pandemic
por: Kortlever, Tim L., et al.
Publicado: (2021)

Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening
por: Knudsen, Amy B., et al.
Publicado: (2023)

Race/Ethnicity, Gender, Weight Status, and Colorectal Cancer Screening
por: Fagan, Heather Bittner, et al.
Publicado: (2011)

Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study
por: de Jonge, Lucie, et al.
Publicado: (2021)

Colorectal cancer risk after removal of polyps in fecal immunochemical test based screening
por: van Toledo, D.E.F.W.M., et al.
Publicado: (2023)

Colorectal Cancer Screening Decision Based on Predicted Risk: Protocol for a Pilot Randomized Controlled Trial
por: Plys, Ekaterina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_5c4q8csul7im3nvh8d5ru0nif3